Press Releases Orphazyme A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 07:47:14 2024-05-03 am EDT			5-day change	1st Jan Change
1,097 ^DKK	+11.00%		+0.64%	-17.52%

Mar. 27	Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 04	FDA Extends Review of Zevra's Arimoclomol by Three Months	DJ

STALICLA Appoints Dr. Thomas Blaettler, MD	Apr. 12	AQ
BioStock: Comments from Orphazyme on the investment in CombiGene	Mar. 04	AQ
The Danish company Orphazyme has acquired 10% of the shares in CombiGene	Feb. 21	AQ
Myositis Pipeline, Clinical Trials Studies, Agreements & Collaborations, and Latest News 2023 (Updated)	23-10-10	AQ
Niemann-Pick-Disease Pipeline, FDA Approvals, Clinical Trials, and Emerging Drugs 2023 (Updated)	23-09-28	AQ
Change in management	23-05-30	GL
Major shareholder announcement	23-05-19	GL
Major shareholder announcement	23-05-17	GL
Resolutions passed at the Annual General Meeting	23-05-17	GL
Changes to the Board of Directors	23-05-17	AQ
Changes to the Board of Directors	23-05-17	GL
Major shareholder announcement	23-05-12	GL
Major shareholder announcement	23-05-09	GL
Major shareholder announcement	23-05-09	GL
Major shareholder announcement	23-05-09	AQ
Notice to convene Annual General Meeting	23-04-25	GL
Notice to convene Annual General Meeting	23-04-25	AQ
Adjusted financial outlook for 2022	22-09-25	GL
Adjusted financial outlook for 2022	22-09-25	GL
Updated financial calendar for 2022	22-09-19	GL

No results for this search